WallStreetZenWallStreetZen

NASDAQ: OBIO
Orchestra Biomed Holdings Inc Stock Ownership - Who owns Orchestra Biomed Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Orchestra Biomed Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason AryehDirector2025-09-191,000$2.45
$2.45kBuy
Joshua AielloPrincipal Accounting Officer2025-09-17203$2.46
$499.38Sell
Andrew Lawrence TaylorChief Financial Officer2025-09-1716,102$2.46
$39.61kSell
David P. HochmanChief Executive Officer and Chairperson2025-09-1740,355$2.46
$99.27kSell
David P. HochmanChief Executive Officer and Chairperson2025-09-173,283$2.46
$8.08kSell
Darren ShermanPresident and Chief Operating Officer2025-09-0340,340$2.72
$109.72kSell
Eric S. FainDirector2025-08-255,760$2.61
$15.03kBuy
Darren ShermanPresident and Chief Operating Officer2025-08-253,000$2.62
$7.86kBuy
Andrew Lawrence TaylorChief Financial Officer2025-08-252,000$2.55
$5.10kBuy
David P. HochmanChief Executive Officer and Chairperson2025-08-216,000$2.49
$14.94kBuy

1 of 3

OBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OBIO insiders and whales buy or sell their stock.

OBIO Shareholders

What type of owners hold Orchestra Biomed Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP25.81%13,926,708$52.78MInsider
Rtw Investments LP15.39%8,306,062$31.48MInstitution
Medtronic PLC10.88%5,868,916$22.24MInsider
Perceptive Advisors LLC9.81%5,292,556$20.06MInsider
Perceptive Advisors LLC8.51%4,592,556$17.41MInstitution
Roderick Wong5.21%2,808,512$10.64MInsider
Geoffrey Wade Smith3.44%1,855,696$7.03MInsider
Hsac 2 Holdings LLC3.16%1,705,705$6.46MInsider
Vanguard Group Inc2.14%1,157,317$4.39MInstitution
David P. Hochman1.98%1,066,293$4.04MInsider

1 of 3

OBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OBIO33.61%64.76%Net BuyingNet Buying
EPRX5.48%0.00%
MDWD40.84%0.00%
ARMP0.89%99.11%Net Selling
CHRS47.75%18.07%Net Selling
View Top Biotech Stocks

Orchestra Biomed Holdings Stock Ownership FAQ

Who owns Orchestra Biomed Holdings?

Orchestra Biomed Holdings (NASDAQ: OBIO) is owned by 33.61% institutional shareholders, 64.76% Orchestra Biomed Holdings insiders, and 1.63% retail investors. Rtw Investments LP is the largest individual Orchestra Biomed Holdings shareholder, owning 13.93M shares representing 25.81% of the company. Rtw Investments LP's Orchestra Biomed Holdings shares are currently valued at $50.28M.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.